All anti-MBP85–98 antibodies detected in the CFS of patients with MS or NMOSD were locally synthesized in the CNS (AI >1.5) (Figure 3C,F), but no significant difference was found between the groups in the frequency of anti-MBP85–98 antibodies or albumin quotients (Table 1). This evidence concerns the gene ALB and myeloid sarcoma.